The long term objective of this proposal is to establish Protein Arginine Methyltransferases and Dimethyarginine Dimethylaminohydrolase (DDAH), the enzymes responsible for methylarginine synthesis and metabolism, as a key regulator of endothelial function. It is our hypothesis that the increased plasma ADMA observed in cardiovascular disease is a biomarker of DDAH activity and that many of the endothelial affects attributed to ADMA are directly manifested through altered DDAH-PRMT activity. We have shown that in addition to the direct effects of ADMA on eNOS activity, DDAH modulates endothelial NO production through ADMA independent mechanisms involving altered protein-methylation and amino acid metabolism. The goals of the current proposal are to: 1.) identify the pathways of ADMA metabolism in the endothelium;2.) determine the mechanisms through which DDAH modulates endothelial protein-arginine methylation and define the effects of protein methylation on endothelial function;3.) determine the mechanisms through which DDAH regulates endothelial L-arginine metabolism and the consequences on endothelial NO production;and 4.) identify the mechanisms through which the PRMT-DDAH-ADMA axis regulates endothelial function and atherosusceptibility. For each of these aims, a combination of cellular, molecular, biophysical and physiological approaches will be used to characterize the effects of DDAH on endothelial function using in vitro and in vivo models. Results from these studies will provide fundamental mechanistic information regarding the mechanisms through which the PRMT-DDAH-ADMA axis modulates cellular function and may lead to new approaches to treat vascular disease.
This research is relevant to public health since atherosclerosis is among the leading cause morbidity and mortality in Americans. Our research has discovered new cellular pathways that are involved in the development of vascular diseases. Research supported by this grant may help identify new drugs to treat arterial pathology and could improve the quality of life of people suffering from cardiovascular disease.
|Velayutham, Murugesan; Hemann, Craig F; Cardounel, Arturo J et al. (2016) Sulfite Oxidase Activity of Cytochrome c: Role of Hydrogen Peroxide. Biochem Biophys Rep 5:96-104|
|Lynch 4th, Thomas L; Sivaguru, Mayandi; Velayutham, Murugesan et al. (2015) Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation. Oxid Med Cell Longev 2015:424751|
|Li, Yuanjing; Cai, Ming; Sun, Qinghua et al. (2013) Hyperoxia and transforming growth factor Î²1 signaling in the post-ischemic mouse heart. Life Sci 92:547-54|
|Sindler, Amy L; Reyes, Rafael; Chen, Bei et al. (2013) Age and exercise training alter signaling through reactive oxygen species in the endothelium of skeletal muscle arterioles. J Appl Physiol (1985) 114:681-93|
|Shenoy, Vinayak; Gjymishka, Altin; Jarajapu, Yagna P et al. (2013) Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. Am J Respir Crit Care Med 187:648-57|
|Bonilla, Ingrid M; Sridhar, Arun; Nishijima, Yoshinori et al. (2013) Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology. J Cardiovasc Pharmacol 61:401-7|
|Zweier, Jay L; Chen, Chun-An; Druhan, Lawrence J (2011) S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling. Antioxid Redox Signal 14:1769-75|
|Chen, Chun-An; Lin, Cho-Hao; Druhan, Lawrence J et al. (2011) Superoxide induces endothelial nitric-oxide synthase protein thiyl radical formation, a novel mechanism regulating eNOS function and coupling. J Biol Chem 286:29098-107|
|Karuppiah, Kanchana; Druhan, Lawrence J; Chen, Chun-an et al. (2011) Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanism. Am J Physiol Heart Circ Physiol 301:H903-11|
|Thomazella, Maria Cristina D; GÃ³es, Marisa F S; Andrade, ClÃ¡udia R et al. (2011) Effects of high adherence to mediterranean or low-fat diets in medicated secondary prevention patients. Am J Cardiol 108:1523-9|
Showing the most recent 10 out of 16 publications